Preethi Sundaram - 27 Dec 2022 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Strategy Officer
Signature
/s/ Preethi Sundaram
Issuer symbol
CPRX
Transactions as of
27 Dec 2022
Net transactions value
$0
Form type
4
Filing time
29 Dec 2022, 15:49:47 UTC
Previous filing
15 Nov 2022
Next filing
17 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Award $0 +68,000 +20% $0.000000 410,500 27 Dec 2022 Common Stock 68,000 $18.59 Direct F1
transaction CPRX Restricted stock units Award $0 +20,000 +4.9% $0.000000 430,500 27 Dec 2022 Common Stock 20,000 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Derivative securities vest in equal tranches, 1/3rd on December 27, 2023, 1/3rd on December 27, 2024 and 1/3rd on December 27, 2025.
F2 Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
F3 Shares of common stock will be delivered to the Reporting Person upon vesting.